NCT05494229

Autologous Blood for Full-thickness Macular Hole

Autologous Whole Blood for Closing Full-thickness Macular Hole

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Omer Othman Abdullah · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Autologous blood for primary and recurrent holes

Detailed description

Utilizing whole autologous blood for closing both primary and recurrent holes. Here, we apply a drop of the taken whole blood over the hole, and the access blood will be aspirated on the macula with a silicon-tipped active back-flash cannula, to abolish all the possibilities of the fibrinogenic behavior of the whole blood composition, which might cause traction and recurrent hole formation. Therefore, only the hole will be filled with blood. The blood will be taken under completely sterile and aseptic conditions. The air infusion will be raised after the valve of one of the trocars will be removed, to allow the air current to dry the clot inside the hole rapidly. Then air gas exchange will be performed to allow the clot to remain away from intraocular fluids for one to two weeks and abolish the possibility of the clot being dissolved.

Conditions

• Ophthalmopathy

Interventions

Type	Name	Description
OTHER	Pars-plana vitrectomy	Pars-plana vitrectomy

Timeline

• Start date: 2022-09-01
• Primary completion: 2023-03-01
• Completion: 2023-03-01
• First posted: 2022-08-09
• Last updated: 2023-03-27

Locations

1 site across 1 country: Iraq